AI news impact · US stocks

Hims & Hers Health, Inc. Class A (HIMS) news impact

On 2026-11-11 Wave Radar's AI rated the news on Hims & Hers Health, Inc. Class A as major negative (impact score −75%).

FTC expanded its billing and privacy lawsuit against Hims & Hers with five states joining. The company also missed Q3 estimates, saw margin contraction, and cut 2026 adjusted EBITDA guidance.

Direction
Major negative
Impact score
−75%
Confidence
90%
Headlines read
5
Flags
Major risk
Date
2026-11-11
Open HIMS news in Wave Radar

AI assessment

Escalating regulatory litigation combined with weak earnings and lower profitability guidance create severe dual headwinds.

Sector impact

Telehealth and DTC pharmaceutical providers face heightened regulatory oversight and margin scrutiny.

Headlines the AI read

Rating history

One rating per trading day the stock was covered.

More on Hims & Hers Health, Inc. Class A

HIMS valuation · HIMS gamma exposure

How the rating works

After each close Wave Radar collects the day's headlines and filings for a stock and asks an AI model what they mean for it. The rating is one of five levels from major negative to major positive; the impact score runs from −100% to +100%, and a rating built on a single uncorroborated source is capped. It describes the news, not the price outlook.

Figures are generated automatically from Wave Radar's published market data and refresh after each market close.